Drug Delivery Business
网页Stevanato Group expands large-volume drug delivery offerings. October 1, 2024 By Sean Whooley. Stevanato Group announced today that it expanded the capacity of its Vertiva on-body device for subcutaneous large-volume drug delivery. The Italy-based company says its Vertiva platform now covers 10mL volumes.
8 drug delivery innovations you should know
网页2023年7月20日 — Innovations in drug delivery never stop, and over the past 12 months or so a wide variety have been in the spotlight. Constant progress continues in the diabetes space, both in the form of insulin delivery and other drug delivery methods. Elsewhere, we see implants, patches, syringes and more showcasing …
The biggest diabetes tech stories out of ADA 2024 - Drug Delivery …
网页June 25, 2024 By Sean Whooley. Some of the diabetes technology on display at ADA 2024. [Images courtesy of Dexcom, Abbott, Senseonics, Insulet, Sequel Med Tech, Tandem Diabetes Care and Medtronic] The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech.
Biora Therapeutics has positive oral drug delivery device data
网页2024年7月2日 — The NaviCap oral drug delivery system. [Image courtesy of Biora Therapeutics] Biora Therapeutics shared positive topline results from a trial of its orally administered drug-device combination for treating ulcerative colitis (UC). BT-600, a proprietary liquid formulation of tofacitinib, is delivered directly to the colon using Biora’s ingestible NaviCap device.
6 drug delivery innovations you need to know | DDBN
网页2022年7月19日 — More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some of those technologies, plus introductions to others, here are some more impressive developments you should keep an eye on: 1. Needle-free delivery. Vaccines have become a major …
FDA approves next-gen drug delivery system from Medtronic
网页October 10, 2023 By Sean Whooley. The SynchroMed III system. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity.
MannKind has more positive inhaled insulin data
网页3 天之前 — A person uses Afrezza inhaled insulin powder. [Image courtesy of MannKind] MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional delivery methods. The Danbury, Connecticut-based company designed Afrezza, a rapid-acting inhaled human insulin, to improve glycemic control in adults with type 1 diabetes mellitus.
Drug-Device Combinations Archives - Drug Delivery Business
网页6 天之前 — PCI Pharma Services makes $365M investment in drug delivery device manufacturing. September 25, 2024 By Sean Whooley. PCI Pharma Services announced that it’s investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and …
Pharmaceuticals Archives - Drug Delivery Business
网页2024年9月25日 — PCI Pharma Services makes $365M investment in drug delivery device manufacturing. September 25, 2024 By Sean Whooley. PCI Pharma Services announced that it’s investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and …
Viatris, Kindeva win FDA approval for first generic version of ...
网页2022年3月16日 — Viatris (Nasdaq:VTRS) and Kindeva Drug Delivery announced today that the FDA approved its generic version of AstraZeneca’s Symbicort.. In March 2021, the FDA granted tentative approval to Breyna (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol) — the first generic version of Symbicort.Today, the agency granted approval for the abbreviated new drug application (ANDA) for the ...